Showing results (51-60 of 192) with videos related to

Sort By:
Pageof 20
Cancer Medicine|September 30, 2016
The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanomaLeila Khoja, Eshetu G Atenafu, Arnoud Templeton, et al.
Clinical Genitourinary Cancer|July 5, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancerSrikala S Sridhar, Anthony M Joshua, Richard Gregg, et al.
European Urology Open Science|November 29, 2023
Circulating Tumour DNA Biomarkers Associated with Outcomes in Metastatic Prostate Cancer Treated with Lutetium-177-PSMA-617Megan Crumbaker, Leonard D Goldstein, David H Murray, et al.
The Journal of Urology|July 21, 2016
AR-V7 Transcripts in Whole Blood RNA of Patients with Metastatic Castration Resistant Prostate Cancer Correlate with Response to Abiraterone AcetateTilman Todenhöfer, Arun Azad, Craig Stewart, et al.
Cancer|April 12, 2021
To ban or not to ban tanning bed use for minors: A cost-effectiveness analysis from multiple US perspectives for invasive melanomaAntoine Eskander, Kathryn E Marqueen, Heather A Edwards, et al.
BJC Reports|February 3, 2026
Obesity, metformin prescription and risk of advanced prostate cancer in non-diabetic menVisalini Nair-Shalliker, Albert Bang, Rani Radhika-Chand, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2008
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcomeMaisa Yoshimoto, Anthony M Joshua, Isabela W Cunha, et al.
Journal of Translational Medicine|January 15, 2016
Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trialRaya Leibowitz-Amit, Melania Pintilie, Leila Khoja, et al.
European Urology|January 19, 2021
Significantly Minimizing Drug Wastage and the Cost of Cabazitaxel Used to Treat Metastatic Castration-Resistant Prostate CancerDi Maria Jiang, Nazanin Fallah-Rad, Roy Lee, et al.
European Urology|June 13, 2020
Five-year Survival Prediction and Safety Outcomes with Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer from the PREVAIL TrialAndrew J Armstrong, Ping Lin, Bertrand Tombal, et al.
Pageof 20